A. Justin Lampropoulos began his career in medical device technology in 2005 and has since led organisations to significant growth, including driving a $1 billion company. His leadership has shaped global commercial strategies, marketing, and corporate growth across multiple geographies. With extensive experience in minimally invasive specialties, he has been involved in nearly $1 billion in mergers, acquisitions, licensing, and distribution deals, spanning early to late-stage technologies.In 2022, Lampropoulos founded MDev Healthcare Innovations BV (MDHI), a global medical technology incubator and accelerator headquartered in Belgium. MDHI focuses on high-potential medical device segments, launching SYNDEO Medical in collaboration with a leading U.S.-based strategic. SYNDEO Medical specializes in manufacturing innovative procedural solutions targeted at cardiac, vascular, oncology, and peripheral vascular sectors.SYNDEO Medical has quickly garnered industry recognition, receiving accolades such as Business Worldwide’s (UK) Top 20 Most Innovative Companies to Watch in 2023. Lampropoulos himself has been honored with numerous industry awards, including the ‘40 Under 40 Generation Next’ by Medical Device and Diagnostic Magazine, a Bronze Telly Award for Marketing, and ‘Sales and Marketer of the Year’ by Utah Business Magazine.During his tenure at Merit Medical (NYSE: MMSI), the company was ranked 66th in the top 100 largest medtech firms in the world (2022) by Medical Design and Outsourcing. Lampropoulos’ leadership was pivotal in driving the company to this scale and recognition.Academy-trained in professional aeronautics, Lampropoulos holds a postgraduate diploma in Strategic Management from the University of Oxford and is an alumnus of Harvard Business School’s EMBA-alternate, the Program for Leadership Development (PLDA).